SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan O. who wrote (5618)9/15/1998 12:58:00 PM
From: Mike McFarland  Read Replies (3) of 9719
 
Does anybody have a feel for how many companies
are working with AAV? In the Journal today there
was an article about Novartis, and they mentioned
a company they acquired a year or two ago (I believe
it was something like 'Genetic Holdings')--anyway
they mentioned in the caption their work with adeno-
associated virus.

I follow TGEN, and it's been on the move a bit lately (sadly,
without me). Was curious if any of the other companies
working with AAV as gene therapy vector are also moving.

Here is the TGEN article, it is a little old
seattletimes.com

And now for sume humor--I saw a large block of ARIA trade
yesterday, naturally, I used the money I had earmarked for
TGEN to add to my pile of Ariad. Oops, could of had more
aria today $1/2 cheaper:-(

--MM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext